Evidence map›Paper›PMID 34466622›Full record

ArticleGalen medical journal2020

The Short-Term Effects of

Maryam Ostovan, Mohammad Hossein Anbardar, Hajar Khazraei, Seyyed Mohammad Bagher Fazljou, Zahra Khodabandeh, Seyedeh Azra Shamsdin, Mostafa Araj Khodaei, Mohammadali Torbati

Open access · diamondAbstract read
In one paragraph

Article in Galen medical journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Maryam OstovanDepartment of Persian Medicine, School of Traditional Medicine, Tabriz University of Medical sciences, Tabriz, Iran.
Mohammad Hossein AnbardarDepartment of Pathology, Medicine Faculty, Shiraz University of Medical Sciences, Shiraz, Iran.
Hajar KhazraeiColorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Seyyed Mohammad Bagher FazljouDepartment of Persian Medicine, School of Traditional Medicine, Tabriz University of Medical sciences, Tabriz, Iran.
Zahra KhodabandehStem cell Technology Research Center, Khalili Street, Research Tower, Shiraz University of Medical Science, Shiraz, Iran.
Seyedeh Azra ShamsdinGastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Mostafa Araj KhodaeiDepartment of Persian Medicine, School of Traditional Medicine, Tabriz University of Medical sciences, Tabriz, Iran.
Mohammadali TorbatiDepartment of Traditional Pharmacy, School of Traditional medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Tabriz University of Medical Sciences · IRShiraz University of Medical Sciences · IRShiraz University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVegetable oils recently have been evaluated in many tissues. MATERIALS AND

methodsTwenty-one male Sprague-Dewley rats were assigned to three groups randomly: (A) control, (B) mastic oil (400 mg/kg), and (C) sesame oil (2cc/kg). The effects of these oils were investigated by determining histopathological and stereological parameters after six days, and the anticancer effects were evaluated on SW48, HepG2 human cell lines.

resultsA mild chronic interstitial inflammation was seen in just one kidney of mastic oil group (B) and the other ones were normal. In the sesame oil group (C), mild chronic interstitial inflammation was seen in six kidneys. In the liver samples of both groups, there were no specific pathological findings. Different concentrations of mastic oil (0.1%-5%) reduced the cell viability of SW48, HepG2, HEK293t, and human fat cells.

conclusionMastic and sesame oils have some side-effects on the kidney and might not be safe at high doses in rats. Sesame oil did not have any toxic effect on HepG2 and HEK293t human cancer cells. Mastic oil treatment has inhibited specific SW48 cells, so this oil seems to be a good adjuvant to chemotherapy in colon treatments.

Indexed as

KidneyLiverMasticRatsSesame Oil

Identifiers

PMID34466622
PMCPMC8343819
OpenAlexW3114315684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.